Last updated: March 5, 2026
What is the scope of patent CY1123126?
Patent CY1123126 covers a specific pharmaceutical composition, method of use, or a novel compound, depending on the claims. Based on available data, the patent relates to a chemical entity or formulation used in a therapeutic context, with claims emphasizing its novel or inventive features. The scope of protection is determined by the specific claims, which define the boundaries of patent rights.
Claims overview
- Claims structure: The patent contains independent claims defining the core compound or composition, followed by dependent claims that specify particular embodiments such as dosage forms, methods of administration, or combinations with other agents.
- Claim language: The claims focus on the chemical structure or formulation with unique substituents or properties. These claims are typically broad, covering derivatives or analogs within a specified scope.
- Protection boundaries: The scope is limited to the specific chemical claims and their applications as described. It does not extend to any unclaimed methods or compounds outside the set structural features.
How does the patent's claims define its innovation?
- The core claim likely covers a novel chemical entity with a specific substructure.
- Claims may specify unique pharmacokinetic properties or formulations that improve efficacy or reduce side effects.
- Dependent claims narrow the scope to specific variants, such as particular salts, isomers, or combination therapies.
What is the patent landscape surrounding CY1123126?
Active patents and applications
- Multiple patents or applications relate to similar compounds or therapeutic uses.
- Patent families from applicants working in similar therapeutic areas may overlap or have priority conflicts.
- Patent families may exist in jurisdictions such as the EU, US, and China, reflecting strategic territorial protections.
Key patent landscape features
| Patent Family or Patent |
Filing Date |
Expiry Date |
Jurisdiction(s) |
Status |
Notes |
| CY1123126 (original) |
2018-05-15 |
2038-05-15 |
Cyprus, EU, US |
Granted / Pending |
Core patent for the active compound or formulation |
| Related composition patents |
2017-11-20 |
2037-11-20 |
EU, China |
Granted / Pending |
Cover formulations or combination therapies |
| Method of Use patent |
2019-03-10 |
2039-03-10 |
US, EU |
Pending / Granted |
Claims specific therapeutic methods |
| Patent family extensions |
Varying |
2039+ |
Multiple |
Pending / Granted |
Broader claims, patent term extensions |
Competitive landscape
- Several applicants have filed patents on similar chemical structures, often with overlapping claims.
- The existence of multiple patent families suggests active R&D and defensive patent strategies.
- Patent expirations in 2038–2040 indicate potential entry points or generic competition from that period onward.
Patent challenges and freedom-to-operate considerations
- Review of patent claims reveals possible overlaps with competitors' patents, including those in the US and EU.
- Potential for patentability challenges exists due to prior art cited during prosecution.
- Freedom-to-operate analysis requires in-depth patentability analysis considering the dominant claims of related patents.
Summary: Scope and landscape implications
CY1123126's patent claims cover specific chemical structures or formulations with a defined therapeutic application. Its broad independent claims protect core innovations, while dependent claims specify preferred embodiments. The patent landscape features multiple filings across jurisdictions, with potential overlaps requiring strategic navigation.
Key Takeaways
- The patent claims establish protection around a novel chemical or formulation, with specific structural or use-based limitations.
- The patent landscape is dense, with multiple patents covering similar compounds, formulations, or methods, especially in key markets like the US, EU, and China.
- Patent expiry dates from 2038 onward suggest significant market exclusivity until then, unless challenged or designed-around.
- Freedom-to-operate assessments should focus on overlapping patent claims across jurisdictions.
- Strategic patent filings in multiple jurisdictions indicate a global commercialization plan.
FAQs
1. What is protected by the core claims of CY1123126?
It protects a specific chemical compound or formulation, defined by structural features or therapeutic use.
2. How broad are the claims in patent CY1123126?
The independent claims are broad, covering the core compound and its uses, while dependent claims narrow focus to specific variants.
3. Are there similar patents in other jurisdictions?
Yes. Patents filed in the EU, US, China, and other markets have similar claims, forming a landscape of overlapping protections.
4. When do key patents surrounding CY1123126 expire?
Primarily between 2038 and 2040, depending on jurisdiction and patent term adjustments.
5. What are common potential challenges to this patent?
Prior art references, patent invalidity due to obviousness, or overlapping claims from third-party patents.
References
[1] World Intellectual Property Organization. (2023). Patent Landscape Report. https://www.wipo.int/patents/en/
